What's new

Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolone, Date of authorisation: 09/02/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolone, Date of authorisation: 09/02/2024, Revision: 6, Status: Authorised

Mar 4, 2025 - 14:42
 0
Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolone, Date of authorisation: 09/02/2024, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolone, Date of authorisation: 09/02/2024, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Atara, reeling from FDA hold on Ebvallo, lays off half of workforce

Next Article

Travel goods brand Monos secures B Corp certification

Related Posts

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 13/11/2013, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0

World Health Organization (WHO)

World Health Organization (WHO)

Feb 21, 2025  0

EMEA-003350-PIP01-23

EMEA-003350-PIP01-23

Feb 19, 2025  0